Summary:
breast cancer patients may be spared chemotherapy thanks to new tests that pinpoint genetic ' markers ' in the tumour and determine its aggressiveness .
a low score meant her chances of recurrence within ten years were just five per cent and she was told chemotherapy could not offer much better odds . '
